PA
VREX icon

PharVision Advisers’s Varex Imaging VREX Stock Holding History

PharVision Advisers’s Portfolio VREX Stock Details VREX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-32,142
Closed -$399K – 1029
2025
Q3 		$399K Buy
+32,142
New +$319K 0.22% 83
2025
Q2 		– Sell
-15,313
Closed -$178K – 441
2025
Q1 		$178K Buy
+15,313
New +$203K 0.25% 212

Other funds holding VREX

Pzena Investment Management
Pzena Investment Management New York $34.1B AUM 23.81% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $65.2B AUM 39.42% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
CB
Cooke & Bieler Philadelphia, Pennsylvania $8.65B AUM 9.66% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
FCM
Frontier Capital Management Boston, Massachusetts $10.7B AUM 67.78% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
RHJA
Rice Hall James & Associates San Diego, California $2.05B AUM 43.16% 1-Year Est. Return

PharVision Advisers's VREX Position: Q4 2025 in Review

PharVision Advisers sold out of Varex Imaging (VREX) in Q4 2025, closing a stake of 32,142 shares — an estimated $399K sold.

PharVision Advisers first reported a position in VREX in Q1 2025 and held it in 2 quarters. The position peaked at $399K in Q3 2025. 179 funds tracked by Wall St. Rank hold VREX as of Q4 2025.

  • PharVision Advisers reported no remaining Varex Imaging position as of Q4 2025 after selling out during the quarter.
  • PharVision Advisers sold 32,142 Varex Imaging shares in Q4 2025, an estimated $399K.
  • PharVision Advisers first reported a position in Varex Imaging in Q1 2025 and held it in 2 quarters.
  • PharVision Advisers's Varex Imaging position peaked at $399K in Q3 2025.
  • 179 funds tracked by Wall St. Rank held Varex Imaging as of Q4 2025.

Based on PharVision Advisers's 13F filing for Q4 2025, filed 17 Feb 2026.